Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 17,201 shares at $15.10 ($259K) on 2019-11-01, disclosed to the SEC on 2019-11-05.
Open-market sale of $259k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.10 | 7,201 | $109K | 41.9% |
| 2 | $15.10 | 7,201 | $109K | 41.9% |
| 3 | $15.28 | 299 | $5K | 1.8% |
| 4 | $14.89 | 2,500 | $37K | 14.4% |
| Total | $15.07 avg | 17,201 | $259K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |